rs16260

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP2BA1

This summary comes from the ClinGen Evidence Repository: The NM_004360.4(CDH1):c.-124-161C>A variant has an allele frequency of 0.27733 (27.73%, 4262/15368 alleles, 578 homozygotes) in the European (Non-Finnish) subpopulation of the gnomAD v2.1.1 cohort (BA1; BP2). Therefore, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the CDH1 Variant Curation Expert Panel (Variant Interpretation Guidelines Version 3.1): BA1, BP2. LINK:https://erepo.genome.network/evrepo/ui/classification/CA122000/MONDO:0100488/007

Frequency

Genomes: 𝑓 0.25 ( 4868 hom., cov: 32)
Exomes 𝑓: 0.27 ( 14920 hom. )

Consequence

CDH1
NM_004360.5 upstream_gene

Scores

2

Clinical Significance

Benign reviewed by expert panel B:5

Conservation

PhyloP100: -0.0220

Publications

206 publications found
Variant links:
Genes affected
CDH1 (HGNC:1748): (cadherin 1) This gene encodes a classical cadherin of the cadherin superfamily. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature glycoprotein. This calcium-dependent cell-cell adhesion protein is comprised of five extracellular cadherin repeats, a transmembrane region and a highly conserved cytoplasmic tail. Mutations in this gene are correlated with gastric, breast, colorectal, thyroid and ovarian cancer. Loss of function of this gene is thought to contribute to cancer progression by increasing proliferation, invasion, and/or metastasis. The ectodomain of this protein mediates bacterial adhesion to mammalian cells and the cytoplasmic domain is required for internalization. This gene is present in a gene cluster with other members of the cadherin family on chromosome 16. [provided by RefSeq, Nov 2015]
CDH1 Gene-Disease associations (from GenCC):
  • blepharocheilodontic syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
  • CDH1-related diffuse gastric and lobular breast cancer syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • hereditary breast carcinoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
  • hereditary diffuse gastric adenocarcinoma
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
  • cleft soft palate
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • orofacial cleft 3
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • blepharocheilodontic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial ovarian cancer
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP2
For more information check the summary or visit ClinGen Evidence Repository.
BA1
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004360.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDH1
NM_004360.5
MANE Select
c.-285C>A
upstream_gene
N/ANP_004351.1A0A0U2ZQU7
CDH1
NM_001317184.2
c.-285C>A
upstream_gene
N/ANP_001304113.1P12830-2
CDH1
NM_001317185.2
c.-1900C>A
upstream_gene
N/ANP_001304114.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDH1
ENST00000261769.10
TSL:1 MANE Select
c.-285C>A
upstream_gene
N/AENSP00000261769.4P12830-1
CDH1
ENST00000422392.6
TSL:1
c.-285C>A
upstream_gene
N/AENSP00000414946.2P12830-2
CDH1
ENST00000566612.5
TSL:1
n.-285C>A
upstream_gene
N/AENSP00000454782.1H3BNC6

Frequencies

GnomAD3 genomes
AF:
0.246
AC:
37459
AN:
152044
Hom.:
4870
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.160
Gnomad AMI
AF:
0.276
Gnomad AMR
AF:
0.288
Gnomad ASJ
AF:
0.395
Gnomad EAS
AF:
0.279
Gnomad SAS
AF:
0.248
Gnomad FIN
AF:
0.237
Gnomad MID
AF:
0.225
Gnomad NFE
AF:
0.280
Gnomad OTH
AF:
0.260
GnomAD4 exome
AF:
0.270
AC:
105718
AN:
392062
Hom.:
14920
AF XY:
0.270
AC XY:
55583
AN XY:
206134
show subpopulations
African (AFR)
AF:
0.156
AC:
1240
AN:
7928
American (AMR)
AF:
0.280
AC:
3852
AN:
13740
Ashkenazi Jewish (ASJ)
AF:
0.384
AC:
4594
AN:
11958
East Asian (EAS)
AF:
0.203
AC:
5170
AN:
25518
South Asian (SAS)
AF:
0.241
AC:
9191
AN:
38184
European-Finnish (FIN)
AF:
0.238
AC:
6712
AN:
28238
Middle Eastern (MID)
AF:
0.314
AC:
563
AN:
1794
European-Non Finnish (NFE)
AF:
0.281
AC:
67835
AN:
241330
Other (OTH)
AF:
0.281
AC:
6561
AN:
23372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
3741
7482
11224
14965
18706
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
298
596
894
1192
1490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.246
AC:
37461
AN:
152162
Hom.:
4868
Cov.:
32
AF XY:
0.246
AC XY:
18294
AN XY:
74374
show subpopulations
African (AFR)
AF:
0.160
AC:
6639
AN:
41546
American (AMR)
AF:
0.287
AC:
4390
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.395
AC:
1372
AN:
3472
East Asian (EAS)
AF:
0.279
AC:
1438
AN:
5154
South Asian (SAS)
AF:
0.249
AC:
1200
AN:
4820
European-Finnish (FIN)
AF:
0.237
AC:
2507
AN:
10594
Middle Eastern (MID)
AF:
0.238
AC:
70
AN:
294
European-Non Finnish (NFE)
AF:
0.280
AC:
19051
AN:
67970
Other (OTH)
AF:
0.257
AC:
543
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1427
2853
4280
5706
7133
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
402
804
1206
1608
2010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.272
Hom.:
10968
Bravo
AF:
0.246
Asia WGS
AF:
0.293
AC:
1017
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
1
CDH1-related diffuse gastric and lobular breast cancer syndrome (1)
-
-
1
Hereditary diffuse gastric adenocarcinoma (1)
-
-
1
Prostate cancer susceptibility (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.73
CADD
Benign
3.9
DANN
Benign
0.71
PhyloP100
-0.022
PromoterAI
0.018
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs16260; hg19: chr16-68771034; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.